Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.23 trillion and total revenue of $109.76 billion.
Market Cap
1.23T
Revenue
109.76B
Profits
-40.61B
PE Ratio
n/a
Profit Margin
-37.00%
Dividend Yield
0.04%
585 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.64B | 1.30% | 342,370 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 67.60B | 1.92% | 182,906 | 14.92B |
| 3 | ARGX | argenx SE | 56.67B | -0.39% | 176,083 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 40.27B | 0.35% | 427,914 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 36.40B | 1.46% | 318,874 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 36.26B | -0.20% | 159,909 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.80B | -0.54% | 937,980 | 2.44B |
| 8 | ROIV | Roivant Sciences Ltd. | 25.51B | 1.05% | 1,511,045 | 8.26M |
| 9 | INCY | Incyte Corporation | 23.54B | 0.96% | 354,413 | 5.36B |
| 10 | INSM | Insmed Incorporated | 23.11B | -0.75% | 396,703 | 819.56M |
| 11 | BNTX | BioNTech SE | 22.74B | -2.31% | 333,841 | 3.23B |
| 12 | MRNA | Moderna, Inc. | 21.72B | -4.02% | 1,969,539 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.78B | -1.37% | 428,697 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 17.00B | 2.07% | 133,762 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.67B | 2.54% | 604,127 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.87B | -0.87% | 111,986 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 13.99B | -0.02% | 312,601 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.60B | 0.59% | 39,014 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.39B | -0.31% | 150,269 | 708.24M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.20B | -0.21% | 574,284 | 622.01M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.43B | 0.42% | 285,783 | 3.24B |
| 22 | ABVX | ABIVAX Société Anonyme | 11.22B | -1.84% | 475,936 | 5.67M |
| 23 | TECH | Bio-Techne Corporation | 11.18B | -0.02% | 980,684 | 1.21B |
| 24 | SMMT | Summit Therapeutics Inc. | 11.16B | -6.61% | 3,677,593 | - |
| 25 | CYTK | Cytokinetics, Incorporated | 11.10B | -0.23% | 446,595 | 105.82M |
| 26 | CORT | Corcept Therapeutics Incorporated | 10.26B | -1.10% | 141,992 | 769.10M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.01% | 190,898 | - |
| 28 | KRYS | Krystal Biotech, Inc. | 9.94B | 2.96% | 163,618 | 417.30M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.70B | 1.16% | 621,663 | 1.51B |
| 30 | IONS | Ionis Pharmaceuticals, Inc. | 9.36B | 1.36% | 675,926 | 1.06B |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.19B | 1.25% | 119,105 | 51.48M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 9.11B | 1.39% | 94,122 | 7.46M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 9.06B | 3.07% | 297,391 | - |
| 34 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.11% | 882,743 | 18.07M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.81B | 1.18% | 81,019 | 74.06M |
| 36 | IMVT | Immunovant, Inc. | 8.08B | -0.08% | 108,731 | - |
| 37 | PCVX | Vaxcyte, Inc. | 7.93B | -1.29% | 219,189 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.78B | -1.05% | 335,886 | 700.35M |
| 39 | IBRX | ImmunityBio, Inc. | 7.62B | -1.62% | 3,515,718 | 140.98M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.16B | 1.78% | 139,728 | 217.17M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 6.90B | -1.03% | 149,219 | 569.61M |
| 42 | COGT | Cogent Biosciences, Inc. | 6.85B | -0.46% | 511,509 | - |
| 43 | ERAS | Erasca, Inc. | 6.83B | 1.81% | 1,084,203 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 6.48B | -0.42% | 219,659 | 827.11M |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.29B | -0.46% | 173,340 | 7.50M |
| 46 | CGON | CG Oncology, Inc. | 6.18B | -1.45% | 117,614 | 5.07M |
| 47 | BLTE | Belite Bio, Inc | 6.09B | -0.95% | 67,109 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.98B | -0.17% | 79,132 | 274.48M |
| 49 | SRRK | Scholar Rock Holding Corporation | 5.87B | -0.97% | 263,977 | - |
| 50 | DFTX | Definium Therapeutics, Inc. | 5.81B | 1.93% | 442,524 | - |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.73B | 0.01% | 204,916 | 1.34M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.66B | 2.04% | 221,171 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.32B | 1.01% | 413,324 | 536.20M |
| 54 | MANE | Veradermics, Incorporated | 4.71B | -2.71% | 283,786 | - |
| 55 | CRSP | CRISPR Therapeutics AG | 4.62B | -1.30% | 584,263 | 4.10M |
| 56 | LEGN | Legend Biotech Corporation | 4.39B | -3.57% | 679,165 | 1.14B |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.39B | 3.74% | 303,244 | - |
| 58 | CAI | Caris Life Sciences, Inc. | 4.38B | -1.09% | 1,252,839 | 907.29M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 4.23B | -0.48% | 172,206 | 1.10B |
| 60 | CELC | Celcuity Inc. | 4.17B | -3.21% | 322,523 | - |
| 61 | DYN | Dyne Therapeutics, Inc. | 4.10B | 3.56% | 1,044,082 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 4.08B | -0.71% | 762,637 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.06B | -2.51% | 420,838 | 10.68M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.96B | -5.26% | 88,486 | - |
| 65 | TNGX | Tango Therapeutics, Inc. | 3.90B | -1.71% | 892,033 | 56.99M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.73B | 1.19% | 118,173 | - |
| 67 | DNLI | Denali Therapeutics Inc. | 3.64B | -2.13% | 374,431 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.63B | -2.89% | 464,843 | 236.00M |
| 69 | NAMS | NewAmsterdam Pharma Company N.V. | 3.62B | 1.39% | 321,308 | 22.57M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.59B | -0.69% | 125,904 | - |
| 71 | ALMS | Alumis Inc. | 3.59B | -0.64% | 441,847 | 8.40M |
| 72 | TLX | Telix Pharmaceuticals Limited | 3.47B | -1.71% | 43,131 | 803.79M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.42B | 0.11% | 227,074 | 415.62M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.41B | -0.90% | 388,761 | 225.27M |
| 75 | MBX | MBX Biosciences, Inc. | 3.02B | -0.20% | 211,293 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.87B | -1.09% | 109,646 | - |
| 77 | CLDX | Celldex Therapeutics, Inc. | 2.77B | -0.45% | 105,193 | 865.00K |
| 78 | KOD | Kodiak Sciences Inc. | 2.66B | 3.80% | 138,428 | - |
| 79 | ATAI | AtaiBeckley Inc. | 2.66B | 0.21% | 2,289,667 | 3.49M |
| 80 | QURE | uniQure N.V. | 2.65B | -2.32% | 512,416 | 18.09M |
| 81 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | -0.59% | 383,815 | 670.00M |
| 82 | VERA | Vera Therapeutics, Inc. | 2.59B | -0.59% | 148,162 | - |
| 83 | BEAM | Beam Therapeutics Inc. | 2.54B | -1.58% | 617,117 | 164.01M |
| 84 | IMNM | Immunome, Inc. | 2.53B | 1.32% | 133,636 | 4.02M |
| 85 | TARS | Tarsus Pharmaceuticals, Inc. | 2.50B | -0.75% | 98,067 | 535.08M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.45B | -0.59% | 327,316 | 36.77M |
| 87 | TRVI | Trevi Therapeutics, Inc. | 2.43B | -0.23% | 504,547 | - |
| 88 | NKTR | Nektar Therapeutics | 2.41B | 2.95% | 326,732 | 55.63M |
| 89 | PHVS | Pharvaris N.V. | 2.38B | 2.47% | 86,651 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | -0.30% | 336,692 | - |
| 91 | VCEL | Vericel Corporation | 2.30B | -0.23% | 82,243 | 292.09M |
| 92 | IOVA | Iovance Biotherapeutics, Inc. | 2.29B | -0.19% | 4,675,947 | 285.61M |
| 93 | NUVB | Nuvation Bio Inc. | 2.28B | 0.77% | 2,020,484 | 143.05M |
| 94 | SLS | SELLAS Life Sciences Group, Inc. | 2.27B | -6.32% | 3,701,764 | - |
| 95 | KLRA | Kailera Therapeutics, Inc. | 2.27B | 0.57% | 257,884 | - |
| 96 | ZLAB | Zai Lab Limited | 2.17B | -1.88% | 173,444 | 453.28M |
| 97 | COAG | Hemab Therapeutics Holdings, Inc. | 2.17B | 1.35% | 244,951 | - |
| 98 | AGIO | Agios Pharmaceuticals, Inc. | 2.17B | 0.41% | 372,447 | 66.05M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 2.14B | 0.44% | 496,974 | 70.92M |
| 100 | BHVN | Biohaven Ltd. | 2.13B | -3.28% | 677,957 | - |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | -0.73% | 88,714 | 899.11M |
| 102 | URGN | UroGen Pharma Ltd. | 2.06B | -0.65% | 110,607 | 140.49M |
| 103 | SION | Sionna Therapeutics, Inc. | 2.05B | 3.00% | 266,707 | - |
| 104 | GLUE | Monte Rosa Therapeutics, Inc. | 2.03B | 4.21% | 273,015 | 42.95M |
| 105 | PVLA | Palvella Therapeutics, Inc. | 2.01B | -1.92% | 66,552 | - |
| 106 | MESO | Mesoblast Limited | 2.01B | -4.42% | 82,372 | 65.38M |
| 107 | NBTX | Nanobiotix S.A. | 2.00B | 1.42% | 48,455 | 38.27M |
| 108 | RAPP | Rapport Therapeutics, Inc. | 1.98B | -0.02% | 87,582 | 20.00M |
| 109 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98B | 0.92% | 243,342 | 298.30M |
| 110 | PGEN | Precigen, Inc. | 1.95B | -1.44% | 852,663 | 31.60M |
| 111 | ZBIO | Zenas BioPharma, Inc. | 1.93B | -1.19% | 168,407 | 10.00M |
| 112 | GHRS | GH Research PLC | 1.91B | 0.98% | 71,170 | - |
| 113 | ADMA | ADMA Biologics, Inc. | 1.90B | -1.85% | 518,525 | 509.86M |
| 114 | KARD | Kardigan, Inc. | 1.90B | -2.08% | 51,926 | - |
| 115 | OCUL | Ocular Therapeutix, Inc. | 1.88B | -0.58% | 444,907 | 52.04M |
| 116 | FTRE | Fortrea Holdings Inc. | 1.86B | 0.87% | 454,814 | 2.71B |
| 117 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -0.60% | 57,513 | 1.20B |
| 118 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | -2.45% | 392,382 | 217.17M |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.83B | -0.84% | 128,584 | 32.08M |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.81B | 0.86% | 210,178 | - |
| 121 | BCAX | Bicara Therapeutics Inc. | 1.81B | -0.77% | 117,707 | - |
| 122 | TYRA | Tyra Biosciences, Inc. | 1.81B | -1.36% | 102,080 | - |
| 123 | IMCR | Immunocore Holdings plc | 1.79B | -0.65% | 68,952 | 412.81M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.78B | -4.37% | 447,475 | 7.47M |
| 125 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.77B | -2.55% | 518,001 | 204.73M |
| 126 | GENB | Generate Biomedicines, Inc. | 1.74B | -2.10% | 113,232 | 30.30M |
| 127 | ABCL | AbCellera Biologics Inc. | 1.67B | -3.35% | 1,976,553 | 79.21M |
| 128 | SRPT | Sarepta Therapeutics, Inc. | 1.67B | -0.38% | 592,012 | 2.18B |
| 129 | AAPG | Ascentage Pharma Group International | 1.66B | -5.18% | 3,298 | 82.08M |
| 130 | ZYME | Zymeworks Inc. | 1.65B | -0.48% | 70,863 | 81.26M |
| 131 | MPLT | MapLight Therapeutics, Inc. | 1.63B | 1.90% | 131,215 | - |
| 132 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | -0.33% | 6,571,860 | 66.41M |
| 133 | MLTX | MoonLake Immunotherapeutics | 1.59B | -0.59% | 132,251 | - |
| 134 | ANAB | AnaptysBio, Inc. | 1.58B | -2.66% | 182,138 | 232.39M |
| 135 | INVA | Innoviva, Inc. | 1.58B | 1.04% | 122,296 | 420.69M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.55B | 1.30% | 43,475 | 20.00M |
| 137 | NTLA | Intellia Therapeutics, Inc. | 1.53B | -1.17% | 1,281,317 | 66.09M |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.52B | 3.52% | 177,866 | - |
| 139 | SEPN | Septerna, Inc. | 1.51B | 0.27% | 107,390 | 72.26M |
| 140 | VIR | Vir Biotechnology, Inc. | 1.49B | -5.25% | 892,878 | 65.50M |
| 141 | XNCR | Xencor, Inc. | 1.45B | -0.05% | 109,609 | 97.36M |
| 142 | SVRA | Savara Inc. | 1.43B | -1.74% | 634,367 | - |
| 143 | FBRX | Forte Biosciences, Inc. | 1.42B | -2.35% | 245,417 | - |
| 144 | AKTS | Aktis Oncology, Inc. | 1.35B | 1.56% | 60,355 | 8.28M |
| 145 | ABSI | Absci Corporation | 1.33B | -2.60% | 947,992 | 1.84M |
| 146 | MNKD | MannKind Corporation | 1.29B | 7.71% | 5,614,051 | 360.78M |
| 147 | AVLN | Avalyn Pharma Inc. | 1.29B | -2.10% | 53,157 | - |
| 148 | IMTX | Immatics N.V. | 1.25B | -1.18% | 184,659 | 43.00M |
| 149 | TRAX | First Tracks Biotherapeutics, Inc. | 1.25B | -4.93% | 197,445 | - |
| 150 | ARDX | Ardelyx, Inc. | 1.25B | -1.56% | 436,174 | 427.68M |
| 151 | NVAX | Novavax, Inc. | 1.24B | -3.26% | 1,201,447 | 596.34M |
| 152 | ORIC | ORIC Pharmaceuticals, Inc. | 1.24B | 10.10% | 1,547,905 | - |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.23B | -1.47% | 78,674 | 1.30M |
| 154 | JBIO | Jade Biosciences, Inc. | 1.18B | 0.97% | 145,465 | - |
| 155 | SPTX | Seaport Therapeutics, Inc. | 1.17B | -0.23% | 8,284 | - |
| 156 | DRTS | Alpha Tau Medical Ltd. | 1.17B | -2.08% | 178,900 | - |
| 157 | CAPR | Capricor Therapeutics, Inc. | 1.14B | -0.78% | 833,579 | 11.13M |
| 158 | WVE | Wave Life Sciences Ltd. | 1.13B | 1.38% | 875,464 | 71.80M |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | -3.00% | 415,916 | - |
| 160 | MGTX | MeiraGTx Holdings plc | 1.11B | -1.32% | 130,948 | 79.76M |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 1.07B | 0.98% | 96,409 | - |
| 162 | ANRO | Alto Neuroscience, Inc. | 1.05B | 1.02% | 105,801 | - |
| 163 | IVA | Inventiva S.A. | 1.04B | -1.55% | 311,715 | 7.94M |
| 164 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 1.09% | 497,473 | 69.64M |
| 165 | EYPT | EyePoint, Inc. | 1.03B | -1.56% | 397,682 | 7.61M |
| 166 | VOR | Vor Biopharma Inc. | 1.03B | 0.05% | 153,218 | - |
| 167 | OLMA | Olema Pharmaceuticals, Inc. | 1.02B | -0.34% | 182,849 | - |
| 168 | LBRX | LB Pharmaceuticals Inc | 1.02B | 2.66% | 112,081 | - |
| 169 | AVTX | Avalo Therapeutics, Inc. | 961.78M | 2.36% | 223,559 | 59.00K |
| 170 | SANA | Sana Biotechnology, Inc. | 956.68M | -0.62% | 645,258 | - |
| 171 | JANX | Janux Therapeutics, Inc. | 936.11M | -2.35% | 166,120 | 13.73M |
| 172 | KURA | Kura Oncology, Inc. | 917.93M | -1.05% | 241,681 | 71.64M |
| 173 | GERN | Geron Corporation | 917.37M | -1.38% | 1,061,799 | 196.12M |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 911.46M | -1.08% | 106,231 | 204.89M |
| 175 | PHAR | Pharming Group N.V. | 891.75M | -2.89% | 2,258 | 369.49M |
| 176 | TBPH | Theravance Biopharma, Inc. | 873.82M | - | 173,740 | 109.78M |
| 177 | ABUS | Arbutus Biopharma Corporation | 873.12M | -1.12% | 244,346 | 191.45M |
| 178 | ANNX | Annexon, Inc. | 872.46M | 0.47% | 1,614,019 | - |
| 179 | ODTX | Odyssey Therapeutics, Inc. | 870.42M | 2.89% | 61,769 | 1.06M |
| 180 | REPL | Replimune Group, Inc. | 836.93M | -4.68% | 766,549 | - |
| 181 | DBVT | DBV Technologies S.A. | 798.75M | -2.16% | 56,920 | 5.04M |
| 182 | AURA | Aura Biosciences, Inc. | 789.74M | -0.56% | 68,662 | - |
| 183 | SLDB | Solid Biosciences Inc. | 777.75M | -1.00% | 255,604 | - |
| 184 | TENX | Tenax Therapeutics, Inc. | 754.63M | 0.89% | 280,848 | - |
| 185 | ACRS | Aclaris Therapeutics, Inc. | 749.99M | -2.01% | 196,068 | 8.37M |
| 186 | DSGN | Design Therapeutics, Inc. | 745.74M | 2.67% | 126,207 | - |
| 187 | CLYM | Climb Bio, Inc. | 732.93M | 0.31% | 147,489 | - |
| 188 | MNPR | Monopar Therapeutics Inc. | 727.62M | 2.76% | 93,229 | - |
| 189 | OMER | Omeros Corporation | 720.86M | -3.11% | 208,375 | 9.89M |
| 190 | CADL | Candel Therapeutics, Inc. | 718.78M | -0.51% | 473,157 | - |
| 191 | SGP | SpyGlass Pharma, Inc. | 718.15M | 2.87% | 45,711 | - |
| 192 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 708.95M | 1.49% | 86,633 | - |
| 193 | FTH | Faeth Therapeutics, Inc. | 707.63M | -1.12% | 77,091 | - |
| 194 | CTMX | CytomX Therapeutics, Inc. | 705.36M | -2.70% | 463,409 | 35.54M |
| 195 | DRUG | Bright Minds Biosciences Inc. | 695.36M | 1.92% | 192,758 | - |
| 196 | NGNE | Neurogene Inc. | 694.45M | -2.02% | 36,204 | 925.00K |
| 197 | CBIO | Crescent Biopharma, Inc. | 683.70M | -2.85% | 37,422 | 11.88M |
| 198 | RIGL | Rigel Pharmaceuticals, Inc. | 673.48M | -1.14% | 182,331 | 299.77M |
| 199 | OCS | Oculis Holding AG | 673.03M | -2.58% | 48,873 | 1.40M |
| 200 | GYRE | Gyre Therapeutics, Inc. | 667.87M | -0.32% | 15,123 | 117.05M |
| 201 | ACHV | Achieve Life Sciences, Inc. | 640.59M | 1.13% | 421,225 | - |
| 202 | NVCT | Nuvectis Pharma, Inc. | 628.15M | -1.12% | 76,465 | - |
| 203 | IMMX | Immix Biopharma, Inc. | 626.47M | - | 1,310,416 | - |
| 204 | MDXG | MiMedx Group, Inc. | 624.08M | 1.45% | 197,370 | 389.42M |
| 205 | AGMB | AgomAb Therapeutics NV | 623.97M | -2.31% | 27,659 | - |
| 206 | ALLO | Allogene Therapeutics, Inc. | 617.83M | -1.65% | 2,485,019 | 22.00K |
| 207 | CRMD | CorMedix Inc. | 617.42M | -2.24% | 153,039 | 400.05M |
| 208 | RGNX | REGENXBIO Inc. | 600.37M | -5.07% | 403,248 | 87.82M |
| 209 | SPRY | ARS Pharmaceuticals, Inc. | 592.84M | -0.50% | 1,214,101 | 98.99M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 579.47M | -2.85% | 28,654 | - |
| 211 | ZVRA | Zevra Therapeutics, Inc. | 561.59M | -24.12% | 4,818,930 | 122.29M |
| 212 | STTK | Shattuck Labs, Inc. | 551.33M | 1.41% | 540,199 | 1.00M |
| 213 | ALT | Altimmune, Inc. | 545.50M | -1.23% | 602,259 | 36.00K |
| 214 | RLMD | Relmada Therapeutics, Inc. | 539.14M | -1.15% | 319,447 | - |
| 215 | FDMT | 4D Molecular Therapeutics, Inc. | 534.00M | -1.59% | 340,463 | 88.24M |
| 216 | VSTM | Verastem, Inc. | 530.76M | -2.27% | 566,121 | 49.59M |
| 217 | SLN | Silence Therapeutics plc | 530.67M | -1.88% | 98,508 | 839.00K |
| 218 | PRME | Prime Medicine, Inc. | 530.11M | -1.18% | 1,116,981 | 4.03M |
| 219 | CTNM | Contineum Therapeutics, Inc. | 529.39M | -1.46% | 27,496 | - |
| 220 | RZLT | Rezolute, Inc. | 528.60M | -4.71% | 373,938 | - |
| 221 | ARVN | Arvinas, Inc. | 523.27M | -0.12% | 105,922 | 89.40M |
| 222 | ANL | Adlai Nortye Ltd. | 522.40M | -1.21% | 37,571 | 5.00M |
| 223 | ASMB | Assembly Biosciences, Inc. | 512.28M | 2.50% | 79,601 | 71.10M |
| 224 | DNA | Ginkgo Bioworks Holdings, Inc. | 499.73M | -3.53% | 309,894 | 151.40M |
| 225 | ZURA | Zura Bio Limited | 499.69M | -0.57% | 104,021 | - |
| 226 | EIKN | Eikon Therapeutics, Inc. | 496.45M | -4.68% | 77,349 | - |
| 227 | SLBT | SL Science Holding Limited | 496.19M | -3.15% | 261,035 | 3.36M |
| 228 | ARTV | Artiva Biotherapeutics, Inc. | 490.98M | -0.25% | 330,262 | 251.00K |
| 229 | HELP | Cybin Inc. | 472.32M | -1.42% | 514,698 | - |
| 230 | PRTA | Prothena Corporation plc | 459.66M | 2.93% | 192,981 | 57.94M |
| 231 | PROK | ProKidney Corp. | 456.11M | -0.66% | 394,330 | 889.00K |
| 232 | VALN | Valneva SE | 449.16M | 1.88% | 3,543 | 180.25M |
| 233 | KYTX | Kyverna Therapeutics, Inc. | 446.54M | 0.75% | 298,441 | - |
| 234 | CABA | Cabaletta Bio, Inc. | 438.62M | -1.10% | 662,020 | - |
| 235 | OVID | Ovid Therapeutics Inc. | 438.60M | -2.08% | 408,384 | 7.12M |
| 236 | SGMT | Sagimet Biosciences Inc. | 432.26M | -0.14% | 232,193 | - |
| 237 | LRMR | Larimar Therapeutics, Inc. | 430.06M | 2.74% | 566,720 | - |
| 238 | IKT | Inhibikase Therapeutics, Inc. | 420.94M | 6.01% | 1,173,402 | 1.00 |
| 239 | OCGN | Ocugen, Inc. | 419.77M | -2.36% | 1,822,079 | 4.47M |
| 240 | SCTX | Scribe Therapeutics Inc. | 417.40M | 58.00% | 394,824 | 36.28M |
| 241 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.72M | -4.29% | 302,743 | - |
| 242 | PBYI | Puma Biotechnology, Inc. | 410.50M | 0.69% | 52,118 | 227.18M |
| 243 | EDIT | Editas Medicine, Inc. | 409.74M | -2.20% | 816,718 | 38.69M |
| 244 | EVMN | Evommune, Inc. | 407.73M | - | 64,248 | 10.00M |
| 245 | AUTL | Autolus Therapeutics plc | 399.21M | -1.32% | 355,045 | 92.62M |
| 246 | BNTC | Benitec Biopharma Inc. | 398.51M | 1.40% | 37,069 | - |
| 247 | VTVT | vTv Therapeutics Inc. | 390.28M | -0.66% | 140,755 | 36.84M |
| 248 | CCCC | C4 Therapeutics, Inc. | 385.88M | -4.38% | 1,005,467 | 34.86M |
| 249 | PRLD | Prelude Therapeutics Incorporated | 385.80M | -1.02% | 91,273 | 16.72M |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 383.33M | 0.84% | 147,420 | - |
| 251 | CMPX | Compass Therapeutics, Inc. | 380.89M | -0.24% | 623,639 | 850.00K |
| 252 | IPSC | Century Therapeutics, Inc. | 376.04M | -3.92% | 107,253 | 109.16M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 374.82M | -0.46% | 24,697 | 69.21M |
| 254 | STRO | Sutro Biopharma, Inc. | 369.02M | -5.64% | 41,251 | 99.61M |
| 255 | LXEO | Lexeo Therapeutics, Inc. | 367.48M | -0.64% | 148,765 | - |
| 256 | DMAC | DiaMedica Therapeutics Inc. | 366.41M | -0.29% | 62,585 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 362.19M | -3.76% | 163,707 | 9.01M |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 356.40M | 1.08% | 25,903 | 51.00M |
| 259 | RCKT | Rocket Pharmaceuticals, Inc. | 353.79M | -1.22% | 557,392 | - |
| 260 | ABEO | Abeona Therapeutics Inc. | 352.80M | -2.98% | 397,437 | 14.54M |
| 261 | UPB | Upstream Bio, Inc. | 352.10M | 1.09% | 211,743 | 3.32M |
| 262 | PALI | Palisade Bio, Inc. | 339.35M | -3.22% | 1,165,684 | - |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 322.15M | -0.09% | 984 | 370.61K |
| 264 | VNDA | Vanda Pharmaceuticals Inc. | 313.31M | -2.80% | 242,812 | 217.78M |
| 265 | ZNTL | Zentalis Pharmaceuticals, Inc. | 311.80M | -1.57% | 547,004 | 26.87M |
| 266 | LYEL | Lyell Immunopharma, Inc. | 308.88M | -1.37% | 20,409 | 31.00K |
| 267 | OABI | OmniAb, Inc. | 300.09M | 1.47% | 117,519 | 28.94M |
| 268 | INDP | Indaptus Therapeutics, Inc. | 299.53M | -4.51% | 38,110 | - |
| 269 | FATE | Fate Therapeutics, Inc. | 289.07M | -1.59% | 450,807 | 6.32M |
| 270 | FHTX | Foghorn Therapeutics Inc. | 284.76M | -4.34% | 51,762 | 28.22M |
| 271 | NMRA | Neumora Therapeutics, Inc. | 281.63M | -2.56% | 332,823 | - |
| 272 | IMRX | Immuneering Corporation | 281.43M | -0.91% | 151,576 | - |
| 273 | ELDN | Eledon Pharmaceuticals, Inc. | 278.29M | -3.74% | 458,326 | - |
| 274 | BCYC | Bicycle Therapeutics plc | 278.20M | -4.21% | 229,130 | 63.50M |
| 275 | AGEN | Agenus Inc. | 272.99M | -1.45% | 406,887 | 123.87M |
| 276 | TTRX | Turn Therapeutics Inc. | 272.86M | -3.38% | 45,677 | - |
| 277 | ALXO | ALX Oncology Holdings Inc. | 271.82M | - | 343,267 | - |
| 278 | SABS | SAB Biotherapeutics, Inc. | 269.54M | -1.54% | 248,450 | 114.70K |
| 279 | SLGL | Sol-Gel Technologies Ltd. | 263.24M | -0.03% | 7,160 | 18.47M |
| 280 | QTTB | Q32 Bio Inc. | 262.82M | 0.78% | 85,346 | 53.74M |
| 281 | LCTX | Lineage Cell Therapeutics, Inc. | 260.52M | -2.34% | 637,748 | 14.78M |
| 282 | OTLK | Outlook Therapeutics, Inc. | 259.93M | 5.30% | 3,672,431 | 333.14K |
| 283 | IFRX | InflaRx N.V. | 257.03M | 0.87% | 225,655 | 33.82K |
| 284 | NAGE | Niagen Bioscience, Inc. | 253.00M | -0.63% | 119,016 | 130.42M |
| 285 | FULC | Fulcrum Therapeutics, Inc. | 251.87M | 0.53% | 187,957 | 80.00M |
| 286 | PRQR | ProQR Therapeutics N.V. | 244.14M | -3.35% | 283,235 | 15.73M |
| 287 | MGNX | MacroGenics, Inc. | 240.90M | -5.49% | 1,652,088 | 157.08M |
| 288 | CNXU | Conexeu Sciences Inc. | 239.49M | -2.19% | 25,097 | - |
| 289 | SRZN | Surrozen, Inc. | 239.17M | -2.65% | 83,055 | 7.49M |
| 290 | IRD | Opus Genetics, Inc. | 237.79M | -1.37% | 427,725 | 11.98M |
| 291 | RNAC | Cartesian Therapeutics, Inc. | 234.02M | 0.57% | 38,016 | 1.78M |
| 292 | GALT | Galectin Therapeutics Inc. | 233.79M | 2.90% | 120,085 | - |
| 293 | TARA | Protara Therapeutics, Inc. | 228.19M | 0.50% | 169,680 | - |
| 294 | OBIO | Orchestra BioMed Holdings, Inc. | 223.36M | 2.47% | 41,537 | 32.72M |
| 295 | AVXL | Anavex Life Sciences Corp. | 223.34M | -2.82% | 543,802 | - |
| 296 | ACIU | AC Immune SA | 220.72M | -0.67% | 309,108 | 4.62M |
| 297 | ADAG | Adagene Inc. | 219.36M | -1.48% | 37,970 | 7.67M |
| 298 | CHRS | Coherus Oncology, Inc. | 219.03M | -0.70% | 199,865 | 46.88M |
| 299 | NAUT | Nautilus Biotechnology, Inc. | 218.58M | -2.82% | 221,727 | - |
| 300 | CGEN | Compugen Ltd. | 217.54M | -1.71% | 76,877 | 72.66M |
| 301 | TRDA | Entrada Therapeutics, Inc. | 214.76M | -1.49% | 159,135 | 5.74M |
| 302 | NBP | NovaBridge Biosciences | 204.70M | - | 97,935 | - |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 203.84M | -1.04% | 153,572 | 7.15M |
| 304 | CLLS | Cellectis S.A. | 203.24M | 6.49% | 7,736 | 75.11M |
| 305 | KROS | Keros Therapeutics, Inc. | 201.68M | 0.49% | 37,391 | 33.18M |
| 306 | RNA | Atrium Therapeutics, Inc. | 201.68M | -1.01% | 32,345 | 36.68M |
| 307 | NERV | Minerva Neurosciences, Inc. | 198.23M | -4.38% | 63,465 | - |
| 308 | PLX | Protalix BioTherapeutics, Inc. | 191.36M | 0.21% | 73,758 | 76.38M |
| 309 | IMUX | Immunic, Inc. | 190.92M | -1.85% | 53,410 | - |
| 310 | MENS | Jyong Biotech Ltd. | 187.81M | -6.64% | 37,252 | - |
| 311 | DTIL | Precision BioSciences, Inc. | 187.32M | -0.95% | 66,308 | 45.07M |
| 312 | GLSI | Greenwich LifeSciences, Inc. | 187.00M | -3.41% | 52,280 | - |
| 313 | VYGR | Voyager Therapeutics, Inc. | 186.10M | -0.32% | 175,913 | 36.49M |
| 314 | ARMP | Armata Pharmaceuticals, Inc. | 185.76M | -3.07% | 31,064 | 5.20M |
| 315 | IVVD | Invivyd, Inc. | 183.45M | 2.22% | 933,774 | 55.87M |
| 316 | ANTX | AN2 Therapeutics, Inc. | 183.32M | 3.46% | 40,638 | - |
| 317 | MDWD | MediWound Ltd. | 182.76M | -0.35% | 10,723 | 14.48M |
| 318 | NGEN | NervGen Pharma Corp. | 176.83M | -0.60% | 239,074 | - |
| 319 | PYXS | Pyxis Oncology, Inc. | 174.23M | 2.61% | 466,338 | 13.86M |
| 320 | ACOG | Alpha Cognition Inc. | 173.98M | -2.92% | 23,175 | 10.83M |
| 321 | HUMA | Humacyte, Inc. | 171.38M | -0.47% | 1,238,459 | 2.02M |
| 322 | LENZ | LENZ Therapeutics, Inc. | 171.19M | 8.12% | 541,462 | 20.99M |
| 323 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 171.01M | -0.97% | 66,151 | - |
| 324 | ORMP | Oramed Pharmaceuticals Inc. | 170.66M | 0.24% | 43,056 | 2.00M |
| 325 | OKUR | OnKure Therapeutics, Inc. | 169.46M | -0.59% | 74,607 | - |
| 326 | KPTI | Karyopharm Therapeutics Inc. | 169.07M | 5.22% | 328,946 | 151.12M |
| 327 | IPHA | Innate Pharma S.A. | 168.14M | 3.69% | 826 | 10.57M |
| 328 | TNYA | Tenaya Therapeutics, Inc. | 165.55M | -1.32% | 1,026,357 | 225.00K |
| 329 | ALEC | Alector, Inc. | 165.43M | - | 107,747 | 18.42M |
| 330 | NRXP | NRx Pharmaceuticals, Inc. | 165.13M | -4.14% | 366,999 | 2.29M |
| 331 | NKTX | Nkarta, Inc. | 164.20M | -0.22% | 181,089 | - |
| 332 | EQ | Equillium, Inc. | 164.07M | -3.53% | 92,167 | 4.39M |
| 333 | KRRO | Korro Bio, Inc. | 163.84M | -1.47% | 44,412 | 3.84M |
| 334 | TNXP | Tonix Pharmaceuticals Holding Corp. | 162.60M | -3.95% | 184,729 | 17.56M |
| 335 | ARCT | Arcturus Therapeutics Holdings Inc. | 161.02M | -2.16% | 165,581 | 54.71M |
| 336 | MIST | Milestone Pharmaceuticals Inc. | 159.95M | -2.02% | 267,141 | 1.78M |
| 337 | CRBU | Caribou Biosciences, Inc. | 159.18M | -1.53% | 426,414 | 11.20M |
| 338 | ABOS | Acumen Pharmaceuticals, Inc. | 157.09M | 0.23% | 127,555 | - |
| 339 | CAMP | Camp4 Therapeutics Corporation | 154.74M | -1.00% | 34,446 | 3.93M |
| 340 | YDES | YD Bio Limited | 154.70M | 7.84% | 47,713 | 510.36K |
| 341 | CNTN | Canton Strategic Holdings, Inc. | 153.09M | -3.64% | 222,066 | - |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 149.02M | -0.37% | 159,055 | - |
| 343 | MOLN | Molecular Partners AG | 148.29M | -1.26% | 131 | 856.30K |
| 344 | PEPG | PepGen Inc. | 143.53M | -1.19% | 366,013 | - |
| 345 | KZIA | Kazia Therapeutics Limited | 141.69M | -4.91% | 110,670 | 1.27M |
| 346 | AARD | Aardvark Therapeutics, Inc. | 139.41M | - | 33,922 | - |
| 347 | CUE | Cue Biopharma, Inc. | 138.25M | -0.53% | 32,924 | 32.73M |
| 348 | CDXS | Codexis, Inc. | 138.16M | -23.62% | 6,081,258 | 78.09M |
| 349 | CNTB | Connect Biopharma Holdings Limited | 136.95M | -1.14% | 236,535 | 233.00K |
| 350 | HURA | TuHURA Biosciences, Inc. | 136.60M | -0.23% | 100,199 | - |
| 351 | ANIX | Anixa Biosciences, Inc. | 132.35M | 3.73% | 186,947 | - |
| 352 | CBUS | Cibus, Inc. | 130.91M | -3.65% | 24,653 | 4.29M |
| 353 | GNLX | Genelux Corporation | 129.45M | -1.52% | 52,072 | 8.00K |
| 354 | GUTS | Fractyl Health, Inc. | 123.49M | 2.87% | 931,867 | 3.00K |
| 355 | ENGN | enGene Therapeutics Inc. | 122.93M | -2.91% | 279,542 | - |
| 356 | TLSA | Tiziana Life Sciences Ltd | 119.96M | -9.05% | 95,494 | - |
| 357 | SPRB | Spruce Biosciences, Inc. | 118.35M | -4.42% | 60,506 | 697.00K |
| 358 | VANI | Vivani Medical, Inc. | 114.69M | -4.32% | 50,964 | - |
| 359 | PMN | ProMIS Neurosciences, Inc. | 113.22M | 0.12% | 44,955 | - |
| 360 | RANI | Rani Therapeutics Holdings, Inc. | 112.14M | 1.71% | 582,219 | 3.17M |
| 361 | SEER | Seer, Inc. | 111.34M | -1.22% | 97,171 | 15.17M |
| 362 | FBIO | Fortress Biotech, Inc. | 111.12M | -2.48% | 158,858 | 66.16M |
| 363 | ENTX | Entera Bio Ltd. | 102.52M | -2.35% | 33,937 | 42.00K |
| 364 | BDTX | Black Diamond Therapeutics, Inc. | 102.28M | -2.99% | 299,780 | 70.00M |
| 365 | PLYX | Polaryx Therapeutics, Inc. | 101.79M | 1.90% | 7,447 | - |
| 366 | ICCC | ImmuCell Corporation | 100.78M | 1.92% | 3,176 | 29.93M |
| 367 | COYA | Coya Therapeutics, Inc. | 100.51M | -2.17% | 63,418 | 7.94M |
| 368 | ONCY | Oncolytics Biotech Inc. | 97.87M | -3.34% | 327,235 | - |
| 369 | PTHS | Pelthos Therapeutics Inc. | 92.21M | -6.58% | 92,616 | 27.70M |
| 370 | BMEA | Biomea Fusion, Inc. | 92.18M | 1.19% | 201,940 | - |
| 371 | VRCA | Verrica Pharmaceuticals Inc. | 91.22M | -2.39% | 6,026 | 37.16M |
| 372 | ALDX | Aldeyra Therapeutics, Inc. | 91.08M | -2.58% | 668,229 | - |
| 373 | NTHI | NeOnc Technologies Holdings, Inc. | 88.43M | -6.06% | 16,016 | 39.99K |
| 374 | KLRS | Kalaris Therapeutics, Inc. | 87.32M | -6.38% | 121,818 | - |
| 375 | RLYB | Rallybio Corporation | 86.31M | -0.61% | 11,466 | 858.00K |
| 376 | HRTX | Heron Therapeutics, Inc. | 85.52M | -1.57% | 557,929 | 150.71M |
| 377 | ATHE | Alterity Therapeutics Limited | 84.91M | -3.41% | 12,912 | 4.43M |
| 378 | CGTX | Cognition Therapeutics, Inc. | 84.58M | -1.58% | 256,949 | - |
| 379 | ACET | Adicet Bio, Inc. | 84.32M | -4.63% | 20,454 | - |
| 380 | NRXS | NeurAxis, Inc. | 83.59M | -3.71% | 20,477 | 4.28M |
| 381 | CSBR | Champions Oncology, Inc. | 83.46M | 0.17% | 7,364 | 57.95M |
| 382 | INO | Inovio Pharmaceuticals, Inc. | 81.00M | -3.48% | 1,484,613 | 65.34K |
| 383 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | 0.86% | 40,218 | - |
| 384 | ALPS | Alps Group Inc | 77.38M | -1.34% | 17,210 | 3.74M |
| 385 | MAIA | MAIA Biotechnology, Inc. | 77.22M | -0.78% | 243,453 | - |
| 386 | OKYO | OKYO Pharma Limited | 76.62M | -1.35% | 7,938 | - |
| 387 | GANX | Gain Therapeutics, Inc. | 76.37M | -1.62% | 327,425 | - |
| 388 | PYPD | PolyPid Ltd. | 76.31M | -6.13% | 129,906 | - |
| 389 | RNTX | Rein Therapeutics Inc. | 75.33M | 1.20% | 189,394 | - |
| 390 | ATRA | Atara Biotherapeutics, Inc. | 72.80M | -1.10% | 43,907 | 23.14M |
| 391 | HYFT | MindWalk Holdings Corp. | 72.51M | 23.73% | 587,184 | 11.43M |
| 392 | ELTX | Elicio Therapeutics, Inc. | 72.23M | -2.22% | 98,790 | - |
| 393 | ANVS | Annovis Bio, Inc. | 71.04M | -4.57% | 612,934 | - |
| 394 | ACRV | Acrivon Therapeutics, Inc. | 69.77M | -2.40% | 78,510 | - |
| 395 | ENLV | Enlivex Ltd. | 69.10M | -1.38% | 43,217 | - |
| 396 | XBIT | XBiotech Inc. | 69.05M | -0.66% | 9,883 | - |
| 397 | LONA | LeonaBio, Inc. | 68.67M | 0.97% | 2,248 | - |
| 398 | OSTX | OS Therapies Incorporated | 68.37M | -1.60% | 105,849 | - |
| 399 | PLRX | Pliant Therapeutics, Inc. | 67.80M | 1.39% | 114,856 | - |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 66.93M | -5.64% | 40,575 | - |
| 401 | IBIO | iBio, Inc. | 66.82M | -3.93% | 196,428 | 300.00K |
| 402 | GOSS | Gossamer Bio, Inc. | 66.09M | -5.12% | 4,602,668 | 55.54M |
| 403 | MNOV | MediciNova, Inc. | 64.98M | 0.77% | 24,510 | 596.64K |
| 404 | SPRO | Spero Therapeutics, Inc. | 63.69M | -5.17% | 5,275,646 | 61.19M |
| 405 | CING | Cingulate Inc. | 62.90M | -3.51% | 31,983 | - |
| 406 | IMA | ImageneBio, Inc. | 62.26M | -0.90% | 2,677 | 800.00K |
| 407 | BOLD | Boundless Bio, Inc. | 57.95M | 2.38% | 104,577 | - |
| 408 | INKT | MiNK Therapeutics, Inc. | 56.05M | 8.59% | 17,266 | - |
| 409 | CRDF | Cardiff Oncology, Inc. | 55.28M | -3.53% | 481,710 | 525.00K |
| 410 | TCRX | TScan Therapeutics, Inc. | 53.88M | -2.60% | 590,532 | 9.14M |
| 411 | CNTX | Context Therapeutics Inc. | 52.95M | -2.71% | 856,690 | - |
| 412 | DWTX | Dogwood Therapeutics, Inc. | 52.13M | 0.65% | 5,222 | - |
| 413 | XLO | Xilio Therapeutics, Inc. | 51.33M | 3.25% | 12,066 | 53.48M |
| 414 | MCRB | Seres Therapeutics, Inc. | 49.48M | -2.29% | 39,324 | 1.15M |
| 415 | IMMP | Immutep Limited | 49.31M | 1.99% | 76,809 | 5.28M |
| 416 | TIL | Instil Bio, Inc. | 48.49M | -0.69% | 2,641 | - |
| 417 | EDSA | Edesa Biotech, Inc. | 47.66M | -5.30% | 28,583 | - |
| 418 | ATYR | aTyr Pharma, Inc. | 47.56M | -2.61% | 283,384 | 190.00K |
| 419 | RADX | Radiopharm Theranostics Limited | 47.20M | -20.51% | 1,248,888 | 10.86M |
| 420 | ELOX | Eloxx Pharmaceuticals, Inc. | 47.02M | -2.92% | 76,633 | - |
| 421 | IBO | Impact BioMedical Inc. | 46.61M | 0.46% | 8,166 | 39.00K |
| 422 | MREO | Mereo BioPharma Group plc | 46.59M | 0.31% | 188,652 | 500.00K |
| 423 | BYSI | BeyondSpring Inc. | 46.47M | 4.63% | 3,984 | 1.88M |
| 424 | VRXA | Veraxa Biotech AG | 45.90M | -2.15% | 116,182 | - |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 45.36M | -1.25% | 35,979 | 22.33M |
| 426 | INMB | INmune Bio Inc. | 45.18M | -1.20% | 71,432 | 50.00K |
| 427 | FLNA | Filana Therapeutics, Inc. | 43.99M | -2.31% | 162,119 | - |
| 428 | DYAI | Dyadic International, Inc. | 43.18M | -2.07% | 94,545 | 3.81M |
| 429 | EXOZ | eXoZymes, Inc. | 42.06M | 5.53% | 364 | -700.00 |
| 430 | APLM | Apollomics, Inc. | 40.87M | -1.33% | 7,024 | 8.84M |
| 431 | HYPD | Hyperion DeFi, Inc. | 39.64M | -0.95% | 164,426 | 1.04M |
| 432 | PDSB | PDS Biotechnology Corporation | 38.69M | -1.04% | 134,891 | - |
| 433 | RNXT | RenovoRx, Inc. | 38.24M | -0.76% | 74,706 | 1.49M |
| 434 | GNTA | Genenta Science S.p.A. | 37.98M | -2.42% | 26,187 | - |
| 435 | GRCE | Grace Therapeutics, Inc. | 37.76M | -1.28% | 47,931 | - |
| 436 | CRVO | CervoMed Inc. | 37.60M | 4.12% | 58,538 | 2.09M |
| 437 | NTRB | Nutriband Inc. | 36.71M | 3.07% | 15,912 | 1.80M |
| 438 | LTRN | Lantern Pharma Inc. | 36.71M | 0.25% | 37,460 | - |
| 439 | VERU | Veru Inc. | 36.43M | -1.73% | 51,486 | 16.89M |
| 440 | NNVC | NanoViricides, Inc. | 35.54M | 1.96% | 192,499 | - |
| 441 | LITS | Lite Strategy, Inc. | 33.90M | 0.45% | 42,336 | - |
| 442 | ESLA | Estrella Immunopharma, Inc. | 32.35M | -1.65% | 73,270 | - |
| 443 | BCTX | BriaCell Therapeutics Corp. | 32.23M | -1.88% | 12,147 | - |
| 444 | SER | Serina Therapeutics, Inc. | 31.19M | -0.48% | 11,070 | 130.00K |
| 445 | ABVC | ABVC BioPharma, Inc. | 29.57M | -2.50% | 56,475 | 797.92K |
| 446 | KYNB | Kyntra Bio, Inc. | 28.94M | 1.13% | 2,256 | 7.44M |
| 447 | ACTU | Actuate Therapeutics, Inc. | 28.47M | -5.56% | 33,637 | - |
| 448 | PLRZ | Polyrizon Ltd. | 28.08M | -2.02% | 1,967 | - |
| 449 | PSTV | Plus Therapeutics, Inc. | 27.46M | 5.56% | 45,511 | 5.18M |
| 450 | ATNM | Actinium Pharmaceuticals, Inc. | 27.30M | -2.35% | 66,728 | 90.00K |
| 451 | IGC | IGC Pharma, Inc. | 26.55M | 0.11% | 138,509 | 1.11M |
| 452 | ALGS | Aligos Therapeutics, Inc. | 25.90M | -10.77% | 106,263 | 4.71M |
| 453 | EVAX | Evaxion A/S | 25.02M | -1.64% | 966 | 7.53M |
| 454 | BRNS | Barinthus Biotherapeutics plc | 24.92M | 1.65% | 10,862 | 14.97M |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 23.90M | -0.47% | 186,322 | - |
| 456 | SKYE | Skye Bioscience, Inc. | 23.61M | -0.46% | 24,976 | - |
| 457 | CELU | Celularity Inc. | 23.25M | 5.68% | 3,828 | 26.55M |
| 458 | MRKR | Marker Therapeutics, Inc. | 21.84M | 3.15% | 28,970 | 3.55M |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 21.03M | -9.18% | 111,659 | - |
| 460 | CVM | CEL-SCI Corporation | 20.62M | -0.83% | 75,912 | - |
| 461 | JSPR | Jasper Therapeutics, Inc. | 20.40M | -0.08% | 331,449 | - |
| 462 | ATOS | Atossa Therapeutics, Inc. | 20.24M | -2.49% | 14,632 | - |
| 463 | HOWL | Werewolf Therapeutics, Inc. | 20.07M | 14.66% | 1,821,892 | 1.14M |
| 464 | NCEL | NewcelX Ltd. | 19.79M | -3.27% | 3,830 | - |
| 465 | GRDX | GridAI Technologies Corp. | 19.73M | -11.49% | 59,172 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 19.40M | -8.42% | 280,353 | -13.27K |
| 467 | CLRB | Cellectar Biosciences, Inc. | 19.27M | -2.37% | 5,687 | - |
| 468 | ALLR | Allarity Therapeutics, Inc. | 19.25M | -0.82% | 23,855 | 345.00K |
| 469 | LGVN | Longeveron Inc. | 19.24M | 0.30% | 98,761 | 1.22M |
| 470 | DARE | Daré Bioscience, Inc. | 18.57M | -1.59% | 103,328 | 1.16M |
| 471 | LSTA | Lisata Therapeutics, Inc. | 18.53M | -4.01% | 17,184 | 170.00K |
| 472 | PLUR | Pluri Inc. | 18.53M | -4.33% | 5,381 | 1.08M |
| 473 | QNTM | Quantum BioPharma Ltd. | 18.16M | - | 21,956 | - |
| 474 | VYNE | VYNE Therapeutics Inc. | 18.07M | -41.33% | 1,825,312 | 454.00K |
| 475 | LPCN | Lipocine Inc. | 17.93M | -0.68% | 12,155 | 2.00M |
| 476 | QNCX | Quince Therapeutics, Inc. | 17.61M | -1.48% | 2,180 | - |
| 477 | TVGN | Tevogen Bio Holdings Inc. | 17.51M | -5.90% | 3,396 | - |
| 478 | PTN | Palatin Technologies, Inc. | 17.10M | 2.46% | 314 | 12.88M |
| 479 | AKTX | Akari Therapeutics, Plc | 15.58M | -4.30% | 18,856 | - |
| 480 | KTTA | Pasithea Therapeutics Corp. | 15.46M | -3.67% | 58,272 | - |
| 481 | OSRH | OSR Health, Inc. | 15.45M | -2.22% | 128,480 | 2.63M |
| 482 | PASG | Passage Bio, Inc. | 15.40M | -2.04% | 42,764 | - |
| 483 | ICU | SeaStar Medical Holding Corporation | 15.36M | 2.15% | 50,887 | 1.44M |
| 484 | CYCN | Cyclerion Therapeutics, Inc. | 15.27M | -0.55% | 26,062 | 1.99M |
| 485 | NXTC | NextCure, Inc. | 14.85M | -1.67% | 121,716 | - |
| 486 | HIND | Vyome Holdings, Inc. | 14.67M | -2.34% | 5,238 | 152.72K |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 14.42M | -1.14% | 97,900 | 5.61M |
| 488 | MLEC | Moolec Science SA | 14.30M | -4.25% | 5,837 | 7.83M |
| 489 | LEXX | Lexaria Bioscience Corp. | 14.13M | -0.04% | 3,451 | 194.00K |
| 490 | TPST | Tempest Therapeutics, Inc. | 13.35M | -4.15% | 100,407 | - |
| 491 | SNTI | Senti Biosciences Holdings, Inc. | 13.16M | -0.94% | 121,391 | 38.00K |
| 492 | COCP | Cocrystal Pharma, Inc. | 12.96M | 2.16% | 4,719 | 225.00K |
| 493 | BLRX | BioLineRx Ltd. | 12.86M | 1.40% | 1,498 | 1.40M |
| 494 | PHIO | Phio Pharmaceuticals Corp. | 12.20M | -1.87% | 53,308 | - |
| 495 | GTBP | GT Biopharma, Inc. | 11.91M | -1.46% | 262,688 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 11.89M | -0.68% | 1,450 | - |
| 497 | INAB | IN8bio, Inc. | 11.82M | 0.85% | 9,595 | - |
| 498 | GDTC | CytoMed Therapeutics Limited | 11.71M | 12.44% | 10,934 | 669.28K |
| 499 | CALC | CalciMedica, Inc. | 11.69M | 3.37% | 223,358 | - |
| 500 | KALA | KALA BIO, Inc. | 11.53M | 1.67% | 83,397 | - |